Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 18, 2021 12:40 ET | Source: Conformis, Inc.

Estudo Clínico: Implantes de Joelhos Específicos para o Paciente com a Tecnologia Conformis são mais econômicos do que as dos implantes de ponta

BILLERICA, Mass., March 18, 2021 (GLOBE NEWSWIRE) -- A Conformis, Inc. (NASDAQ:CFMS) anunciou hoje que uma análise retrospectiva independente dos dados hospitalares concluiu que a tecnologia dos...
March 18, 2021 12:40 ET | Source: Conformis, Inc.

Estudio Clínico: Implante de reemplazo total de rodilla específico para paciente con tecnología Conformis es más económico que implantes tradicionales líderes

BILLERICA, Mass., March 18, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) anunció hoy que un estudio retrospectivo independiente de datos hospitalarios concluyó que la tecnología de...
March 17, 2021 11:56 ET | Source: Conformis, Inc.

Clinical Study: Patient-Specific Total Knee Replacement with Conformis Technology Is More Cost-Effective Than with Leading Off-the-Shelf Implants

BILLERICA, Mass., March 17, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that an independent, retrospective review of hospital data has concluded that Conformis iTotal®...
March 16, 2021 07:00 ET | Source: Conformis, Inc.

Clinical Study: Patient-Specific Total Knee Replacement with Conformis Technology Is More Cost-Effective Than with Leading Off-the-Shelf Implants

BILLERICA, Mass., March 16, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that an independent, retrospective review of hospital data has concluded that Conformis iTotal®...
March 03, 2021 16:05 ET | Source: Conformis, Inc.

Conformis, Inc. Reports Fourth Quarter and Year End 2020 Financial Results

BILLERICA, Mass., March 03, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today financial results for the fourth quarter and year ended December 31, 2020. Fourth Quarter 2020...
March 01, 2021 17:45 ET | Source: Conformis, Inc.

Conformis, Inc. Announces Clearance in Australia for iTotal® PS, the Only Personalized, Posterior-Stabilized Total Knee Replacement System

BILLERICA, Mass., March 01, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) today announced the clearance of its patient-specific iTotal® PS total knee replacement system by the Therapeutic...
February 25, 2021 08:00 ET | Source: Conformis, Inc.

Conformis, Inc. to Participate in Upcoming Investor Conferences

BILLERICA, Mass., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today...
February 12, 2021 08:30 ET | Source: Conformis, Inc.

Conformis, Inc. Announces Pricing of $85 Million Underwritten Offering of Common Stock

BILLERICA, Mass., Feb. 12, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (Nasdaq: CFMS) today announced it has priced an underwritten public offering of 80,952,381 shares of its common stock at an...
February 11, 2021 16:01 ET | Source: Conformis, Inc.

Conformis, Inc. Announces Proposed Public Offering of Common Stock

BILLERICA, Mass., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (Nasdaq: CFMS) today announced that it intends to offer shares of its common stock in an underwritten public offering. Conformis...
January 21, 2021 16:15 ET | Source: Conformis, Inc.

Conformis, Inc. and SITES Medical Announce Development & Supply Agreement

BILLERICA, Mass. and COLUMBIA CITY, Ind., Jan. 21, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) and SITES Medical, a firm dedicated to inventing and de-risking new orthopedic medical...